Share on StockTwits

Shares of Tenet Healthcare Corp (NYSE:THC) have earned an average recommendation of “Hold” from the eighteen ratings firms that are currently covering the company, Analyst Ratings Network.com reports. Ten investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1-year target price among analysts that have updated their coverage on the stock in the last year is $57.79.

Tenet Healthcare Corp (NYSE:THC) opened at 45.16 on Tuesday. Tenet Healthcare Corp has a 1-year low of $36.87 and a 1-year high of $50.25. The stock’s 50-day moving average is $47.46 and its 200-day moving average is $44.63. The company’s market cap is $4.410 billion.

Tenet Healthcare Corp (NYSE:THC) last issued its quarterly earnings data on Monday, May 5th. The company reported ($0.12) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.14) by $0.02. The company had revenue of $3.93 billion for the quarter, compared to the consensus estimate of $3.91 billion. During the same quarter last year, the company posted $0.33 earnings per share. Tenet Healthcare Corp’s revenue was up 66.0% compared to the same quarter last year. On average, analysts predict that Tenet Healthcare Corp will post $1.22 earnings per share for the current fiscal year.

A number of research firms have recently commented on THC. Analysts at S&P Equity Research downgraded shares of Tenet Healthcare Corp to a “hold” rating in a research note on Friday, June 13th. Separately, analysts at Mizuho raised their price target on shares of Tenet Healthcare Corp from $52.00 to $59.00 in a research note on Wednesday, June 11th. They now have a “buy” rating on the stock. Finally, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Tenet Healthcare Corp in a research note on Tuesday, June 3rd. They now have a $57.00 price target on the stock, up previously from $52.00.

Tenet Healthcare Corporation (NYSE:THC) along with its subsidiaries, is an investor-owned health care services company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.